γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin

Genes and Development

Volumn 14, Issue 11, 2000, Pages 1319-1331

  Kolligs, Frank T ^a   Kolligs, Barbara ^a   Hajra, Karen M ^a   Gang, Hu ^a,b   Tani, Masachika ^a   Kathleen R, Cho ^a   Fearon, Eric R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

Author keywords

catenin; catenin; c Myc; Cancer; Plakoglobin; Tcf Lcf; Wnt signaling

Indexed keywords

BETA CATENIN; PLAKOGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ALLELES; ANIMALS; BETA CATENIN; CELL ADHESION; CELL DIVISION; CELL LINE; CELL LINE, TRANSFORMED; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; DESMOPLAKINS; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; GAMMA CATENIN; GENE EXPRESSION REGULATION; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MICE, NUDE; MUTATION; NEOPLASM TRANSPLANTATION; NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0034212818     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Barth, A.I., I.S. Nathke, and W.J. Nelson. 1997. Cadherins, catenins and APC protein: Interplay between cytoskeletal complexes and signaling pathways. Curr. Opin. Cell Biol. 9: 683-690.
2. Behrens, J. 1999. Cadherins and catenins: Role in signal transduction and tumor progression. Cancer Met. Rev. 18: 15-30.
3. Behrens, J., J.P. von Kries, M. Kuhl, L. Bruhn, D. Wedlich, R. Grosschedl, and W. Birchmeier. 1996. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638-642.
4. Ben-Ze'ev, A. and B. Geiger. 1998. Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer. Curr. Opin. Cell Biol. 10: 629-639.
5. Bienz, M. 1999. APC: The plot thickens. Curr. Opin. Genet. Dev. 9: 595-603.
6. Bierkamp, C., H. Schwarz, O. Huber, and R. Kemler. 1999. Desmosomal localization of β-catenin in the skin of plakoglobin null-mutant mice. Development 126: 371-381.
7. Caca, K., F.T. Kolligs, X. Ji, M. Hayes, J. Qian, A. Yahanda, D.L. Rimm, J. Costa, and E.R. Fearon. 1999. β-and γ-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Diff. 10: 369-376.
8. Cadigan, K.M. and R. Nusse. 1997. Wnt signaling: A common theme in animal development. Genes & Dev. 11: 3286-3305.
9. Cohen, P., D.R. Alessi, and D.A. Cross. 1997. PDK1, one of the missing links in insulin signal transduction. FEBS Lett. 410: 3-10.
10. Crawford, H.C., B.M. Fingleton, L.A. Rudolph-Owen, K.J. Goss, B. Rubinfeld, P. Polakis, and L.M. Matrisian. 1999. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene 18: 2883-2891.
11. de La Coste, A., B. Romagnolo, P. Billuart, C.A. Renard, M.A. Buendia, O. Soubrane, M. Fabre, J. Chelly, C. Beldjord, A. Kahn et al. 1998. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. 95: 8847-8851.
12. Erisman, M.D., J.K. Scott, R.A. Watt, and S.M. Astrin. 1988. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines. Oncogene 2: 367-378.
13. Fukuchi, T., M. Sakamoto, H. Tsuda, K. Maruyama, S. Nozawa, and S. Hirohashi. 1998. β-catenin mutation in carcinoma of the uterine endometrium. Cancer Res. 58: 3526-3528.
14. Gamallo, C., J. Palacios, G. Moreno, J. Calvo de Mora, A. Suarez, and A. Armas. 1999. β-catenin expression pattern in stage I and II ovarian carcinomas: Relationship with β-catenin gene mutations, clinicopathological features, and clinical outcome. Am. J. Path. 155: 527-536.
15. Garcia-Rostan, G., G. Tallini, A. Herrero, T.G. D'Aquila, M.L. Carcangiu, and D.L Rimm. 1999. Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma. Cancer Res. 59: 1811-1815.
16. Gat, U., R. DasGupta, L. Degenstein, and E. Fuchs. 1998. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell 95: 605-614.
17. Haegel, H., L. Larue, M. Ohsugi, L. Fedorov, K. Herrenknecht, and R. Kemler. 1995. Lack of β-catenin affects mouse development at gastrulation. Development 121: 3529-3537.
18. Harada, N., Y. Tamai, T. Ishikawa, B. Sauer, K. Takaku, M. Oshima, and M.M. Taketo. 1999. Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene. EMBO J. 18: 5931-5942.
19. Hart, M., J.P. Concordet, I. Lassot, I. Albert, R. del los Santos, H. Durand, C. Perret, B. Rubinfeld, F. Margottin, R. Benarous et al. 1999. The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell. Curr. Biol. 9: 207-210.
20. Hayashi, S., B. Rubinfeld, B. Souza, P. Polakis, E. Wieschaus, and A.J. Levine. 1997. A Diosophila homolog of the tumor suppressor gene adenomatous polyposis coli down-regulates β-catenin but its zygotic expression is not essential for the regulation of Armadillo. Proc. Natl. Acad. Sci. 94: 242-247.
21. He, T.C., A.B. Sparks, C. Rago, H. Hermeking, L. Zawel, L.T. da Costa, P.J. Morin, B. Vogelstein, and K.W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
22. He, T.C., T.A. Chan, B. Vogelstein, and K.W. Kinzler. 1999. PPARS is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345.
23. Hsu, S.C., J. Galceran, and R. Grosschedl. 1998. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with β-catenin. Mol. Cell. Biol. 18: 4807-4818.
24. Huber, O., R. Korn, J. McLaughlin, M. Ohsugi, B.G. Herrmann, and R. Kemler. 1996. Nuclear localization of β-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59: 3-10.
25. Hulsken, J., W. Birchmeier, and J. Behrens. 1994. E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton. J. Cell Biol. 127: 2061-2069.
26. Inomata, M., A. Ochiai, S. Akimoto, S. Kitano, and S. Hirohashi. 1996. Alteration of β-catenin expression in colonie epithelial cells of familial adenomatous polyposis patients. Cancer Res. 56: 2213-2217.
27. Iwao, K., S. Nakamori, M. Kameyama, S. Imaoka, M. Kinoshita, T. Fukui, S. Ishiguro, Y. Nakamura, and Y. Miyoshi. 1998. Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res. 58: 1021-1026.
28. Kawahara K., T. Morishita, T. Nakamura, F. Hamada, K. Toyoshima, and T. Akiyama. 2000. Down-regulation of β-catenin by the colorectal tumor suppressor APC requires association with axin and β-catenin. J. Biol. Chem. 275: 8369-8374.
29. Kinzler, K.W. and B. Vogelstein. 1996. Lessons from hereditary colorectal cancer. Cell 87: 159-170.
30. Kitaeva, M.N., L. Grogan, J.P. Williams, E. Dimond, K. Nakahara, P. Hausner, J.W. DeNobile, P.W. Soballe, and I.R. Kirsch. 1997. Mutations in β-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res. 57: 4478-4481.
31. Kitagawa, M., S. Hatakeyama, M. Shirane, M. Matsumoto, N. Ishida, K. Hattori, I. Nakamichi, A. Kikuchi, K. Nakayama, and K. Nakayama. 1999. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of β-catenin. EMBO J. 18: 2401-2410.
32. Koch, A., D. Denkhaus, S. Albrecht, I. Leuschner, D. von Schweinitz, and T. Pietsch. 1999. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene. Cancer Res. 59: 269-273.
33. Kodama, S., S. Ikeda, T. Asahara, M. Kishida, and A. Kikuchi. 1999. Axin directly interacts with plakoglobin and regulates its stability. J. Biol. Chem. 274: 27682-27688.
34. Kolligs, F.T., G. Hu, C.V. Dang, and E.R. Fearon. 1999. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 19: 5696-5706.
35. -/- colon carcinomas. Science 275: 1784-1787.
36. Maniatis, T. 1999. A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. Genes & Dev. 13: 505-510.
37. Melhem, M.F., A.I. Meisler, G.G. Finley, W.H. Bryce, M.O. Jones, H. Tribbey, J.M. Pipas, and R.A. Koski. 1992. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors. Cancer Res. 53: 5853-5864.
38. Mirabelli-Primdahl, L., R. Gryfe, H. Kim, A. Millar, C. Luceri, D. Dale, E. Holowaty, B. Bapat, S. Gallinger, and M. Redston. 1999. β-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res. 59: 3346-3351.
39. Miyoshi, Y., K. Iwao, Y. Nagasawa, T. Aihara, Y. Sasaki, S. Imaoka, M. Murata, T. Shimano, and Y. Nakamura. 1998. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res. 58: 2524-2527.
40. Molenar, M., M. van de Wetering, M. Oosterwegel, J. Peterson-Maduro, S. Godsave, V. Korinek, J. Roose, O. Destree, and H. Clevers. 1996. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 86: 391-399.
41. Morin, P.J., B. Vogelstein, and K.W. Kinzler. 1995. Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. 93: 7950-7954.
42. Morin, P.J., A.B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, and K.W. Kinzler. 1997. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-1790.
43. Munemitsu, S., I. Albert, B. Souza, B. Rubinfeld, and P. Polakis. 1995. Regulation of intracellular β-catenin levels by the adenomatous polyposis (APC) tumor suppressor protein. Proc. Natl. Acad. Sci. 92: 3046-3050.
44. Park, W.S., R.R. Oh, J.Y. Park, S.H. Lee, M.S. Shin, Y.S. Kim, S.Y. Kim, H.K Lee, P.J. Kim, S.T. Oh et al. 1999. Frequent somatic mutations of the β-catenin gene in intestinal-type gastric cancer. Cancer Res. 59: 4257-4260.
45. Peifer, M. and E. Wieschaus. 1990. The segment polarity gene armadillo encodes a functionally modular protein that is the Drosophila homolog of human plakoglobin. Cell 63: 1167-1176.
46. Peifer, M. and P. Polakis. 2000. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287: 1606-1609.
47. Peifer, M., C. Rauskolb, M. Williams, B. Riggleman, and E. Wieschaus. 1991. The segment polarity gene armadillo interacts with the wingless signaling pathway in both embryonic and adult pattern formation. Development 111: 1029-1043.
48. Polakis P. 1999. The oncogenic activation of β-catenin. Curr. Opin. Genet. Dev. 9: 15-21.
49. Rimm, D.L., K. Caca, G. Hu, F.B. Harrison, and E.R. Fearon. 1999. Frequent nuclear/cytoplasmic localization of β-catenin without exon 3 mutations in malignant melanoma. Am. J. Path. 154: 325-329.
50. Roose, J., G. Huls, M. van Beest, P. Moerer, K. van der Horn, R. Goldschmeding, T. Logtenberg, and H. Clevers. 1999. Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1. Science 285: 1923-1926.
51. Ross, S.E., R.L Erickson, N. Hemati, and O.A. MacDougald. 1999. Glycogen synthase kinase 3 is an insulin-regulated C/EBPα kinase. Mol. Cell. Biol. 19: 8433-8441.
52. Rubinfeld, B., B. Souza, I. Albert, S. Munemitsu, and P. Polakis. 1995. The APC protein and E-cadherin form similar but independent complexes with α-catenin, β-catenin, and plakoglobin. J. Biol. Chem. 270: 5549-5555.
53. Rubinfeld, B., P. Robbins, M. El-Gamil, I. Albert, E. Porfiri, and P. Polakis. 1997. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792.
54. Ruiz, P., V. Brinkmann, B. Ledermann, M. Behrend, C. Grund, C. Thalhammer, F. Vogel, C. Birchmeier, U. Gunthert, W.W. Franke et al. 1996. Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J. Cell Biol. 135: 215-225.
55. Salic A., E. Lee, L. Mayer, and M.W. Kirschner. 2000. Control of β-catenin stability: Reconstitution of the cytoplasmic steps of the Wnt pathway in Xenopus egg extracts. Mol. Cell 5: 523-532.
56. Samowitz, W., M.D. Powers, L.N. Spirio, F. Nollet, F. van Roy, and M.L. Slattery. 1999. β-Catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res. 59: 1442-1444.
57. Satoh, S., Y. Daigo, Y. Furukawa, T. Kato, N. Miwa, T. Hishiwaki, T. Kawasoe, H. Ishiguro, M. Fujita, T. Tokino et al. 2000. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 24: 245-250.
58. Shibata, T., M. Gotoh, A. Ochiai, and S. Hirohashi. 1994. Association of plakoglobin with APC, a tumor suppressor gene product, and its regulation by tyrosine phosphorylation. Biochem. Biophys. Res. Comm. 203: 519-522.
59. Shtutman, M., J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, and A. Ben-Ze'ev. 1999. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. 11: 5522-5527.
60. Simcha, I., B. Geiger, S. Yehuda-Levenberg, D. Salomon, and A. Ben-Ze'ev. 1996. Suppression of tumorigenicity by plakoglobin: An augmenting effect of N-cadherin. J. Cell Biol. 133: 199-209.
61. Simcha, I., M. Shtutman, D. Salomon, J. Zhurinsky, E. Sadot, B. Geiger, and A. Ben-Ze'ev. 1998. Differential nuclear translocation and transactivation potential of β-catenin and plakoglobin. J. Cell Biol. 141: 1433-1448.
62. Sparks, A.B., P.J. Morin, B. Vogelstein, and K.W. Kinzler. 1998. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58: 1130-1134.
63. Su, L.K., B. Vogelstein, and K.W. Kinzler. 1993. Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737.
64. Sutherland, C., I.A. Leighton, and P. Cohen. 1993. Inactivation of glycogen synthase kinase-3β by phosphorylation: New kinase connections in insulin and growth-factor signaling. Biochem. J. 296: 15-19.
65. Tetsu, O. and F. McCormick. 1999. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426.
66. Voeller, H.J., C.I. Truica, and E.P. Gelmann. 1998. β-catenin mutations in human prostate cancer. Cancer Res. 58: 2520-2523.
67. Willert, K. and R. Nusse. 1998. β-catenin: A key mediator of Wnt signaling. Curr. Opin. Genet. Dev. 8: 95-102.
68. Winston, J.T., P. Strack, P. Beer-Romero, C.Y. Chu, S.J. Elledge, and J.W. Harper. 1999. The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes & Dev. 13: 270-283.
69. Wright, K., P. Wilson, S. Morland, I. Campbell, M. Walsh, T. Hurst, B. Ward, M. Cummings, and G. Chenevix-Trench. 1999. β-catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometroid tumours. Int. J. Cancer 82: 625-629.
70. Zurawel, R.H., S.A. Chiappa, C. Allen, and C. Raffel. 1998. Sporadic medulloblastomas contain oncogenic β-catenin mutations. Cancer Res. 58: 896-899.